Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 773

1.

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA; International Antiviral Society-USA Panel.

JAMA. 2014 Jul 23-30;312(4):410-25. doi: 10.1001/jama.2014.8722.

PMID:
25038359
[PubMed - indexed for MEDLINE]
2.

HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.

Marrazzo JM, del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH, Montaner JS, Wheeler DP, Grant RM, Grinsztejn B, Kumarasamy N, Shoptaw S, Walensky RP, Dabis F, Sugarman J, Benson CA; International Antiviral Society-USA Panel.

JAMA. 2014 Jul 23-30;312(4):390-409. doi: 10.1001/jama.2014.7999. Erratum in: JAMA. 2014 Aug 13;312(6):652. JAMA. 2014 Jul 23-30;312(4):403.

PMID:
25038358
[PubMed - indexed for MEDLINE]
3.

Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.

Mugo NR, Hong T, Celum C, Donnell D, Bukusi EA, John-Stewart G, Wangisi J, Were E, Heffron R, Matthews LT, Morrison S, Ngure K, Baeten JM; Partners PrEP Study Team.

JAMA. 2014 Jul 23-30;312(4):362-71. doi: 10.1001/jama.2014.8735.

PMID:
25038355
[PubMed - indexed for MEDLINE]
4.

Integrating HIV prevention into practice.

Mathers BM, Cooper DA.

JAMA. 2014 Jul 23-30;312(4):349-50. doi: 10.1001/jama.2014.8606. No abstract available.

PMID:
25038352
[PubMed - indexed for MEDLINE]
5.

Effectiveness of antiretroviral therapy in individuals who for economic reasons were switched from a once-daily single-tablet regimen to a triple-tablet regimen.

Engsig FN, Gerstoft J, Helleberg M, Nielsen LN, Kronborg G, Mathiesen LR, Obel N.

J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):407-13. doi: 10.1097/QAI.0000000000000199.

PMID:
24984188
[PubMed - indexed for MEDLINE]
6.

Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.

Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM; Partners PrEP Study Team.

Ann Intern Med. 2014 Jul 1;161(1):11-9. doi: 10.7326/M13-2471.

PMID:
24979446
[PubMed - indexed for MEDLINE]
7.

Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone.

Wang Q, Young J, Bernasconi E, Vernazza P, Calmy A, Cavassini M, Furrer H, Fehr J, Bucher HC, Battegay M; Swiss HIV Cohort Study.

HIV Clin Trials. 2014 May-Jun;15(3):92-103. doi: 10.1310/hct1503-92.

PMID:
24947533
[PubMed - indexed for MEDLINE]
8.

Perceptions of emtricitabine-tenofovir in HIV PrEP.

Kruse L, Stover K, Henderson H.

HIV Clin. 2014 Winter;26(1):1, 4-7. No abstract available.

PMID:
24855688
[PubMed - indexed for MEDLINE]
9.

An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda.

Psaros C, Haberer JE, Katabira E, Ronald A, Tumwesigye E, Campbell JD, Wangisi J, Mugwanya K, Kintu A, Enyakoit M, Thomas KK, Donnell D, Krows M, Kidoguchi L, Ware N, Baeten JM, Celum C, Bangsberg DR, Safren SA.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):522-9. doi: 10.1097/QAI.0000000000000212.

PMID:
24853311
[PubMed - indexed for MEDLINE]
10.

Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection.

Amico KR, Marcus JL, McMahan V, Liu A, Koester KA, Goicochea P, Anderson PL, Glidden D, Guanira J, Grant R.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):530-7. doi: 10.1097/QAI.0000000000000216.

PMID:
24853306
[PubMed - indexed for MEDLINE]
11.

A 48-week study of fat molecular alterations in HIV naive patients starting tenofovir/emtricitabine with lopinavir/ritonavir or efavirenz.

Domingo P, Gutierrez Mdel M, Gallego-Escuredo JM, Torres F, Mateo MG, Villarroya J, Lamarca K, Domingo JC, Vidal F, Villarroya F, Giralt M.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):457-65. doi: 10.1097/QAI.0000000000000205.

PMID:
24820106
[PubMed - indexed for MEDLINE]
12.

Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227.

Vogler MA, Smeaton LM, Wright RL, Cardoso SW, Sanchez J, Infante R, Moran LE, Godfrey C, Demeter LM, Johnson VA.

J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):542-50. doi: 10.1097/QAI.0000000000000072.

PMID:
24759064
[PubMed - indexed for MEDLINE]
13.

Switching from twice-daily raltegravir plus tenofovir disoproxil fumarate/emtricitabine to once-daily elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate in virologically suppressed, HIV-1-infected subjects: 48 weeks data.

Mills A, Crofoot G, Ortiz R, Rashbaum B, Towner W, Ward D, Brinson C, Kulkarni R, Garner W, Ebrahimi R, Cao H, Cheng A, Szwarcberg J.

HIV Clin Trials. 2014 Mar-Apr;15(2):51-6. doi: 10.1310/hct1502-51.

PMID:
24710918
[PubMed - indexed for MEDLINE]
14.

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.

Clotet B, Feinberg J, van Lunzen J, Khuong-Josses MA, Antinori A, Dumitru I, Pokrovskiy V, Fehr J, Ortiz R, Saag M, Harris J, Brennan C, Fujiwara T, Min S; ING114915 Study Team.

Lancet. 2014 Jun 28;383(9936):2222-31. doi: 10.1016/S0140-6736(14)60084-2. Epub 2014 Apr 1.

PMID:
24698485
[PubMed - indexed for MEDLINE]
15.

Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.

Kang M, Hollabaugh K, Pham V, Koletar SL, Wu K, Smurzynski M, Aberg JA.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):172-80. doi: 10.1097/QAI.0000000000000149.

PMID:
24694927
[PubMed - indexed for MEDLINE]
16.

Single-tablet, once-daily treatment regimens for HIV.

Sawyer JR, Ma Q, Hsiao CB.

Lancet Infect Dis. 2014 Apr;14(4):265-7. doi: 10.1016/S1473-3099(14)70026-X. No abstract available. Erratum in: Lancet Infect Dis. 2014 Jun;14(6):448.

PMID:
24670622
[PubMed - indexed for MEDLINE]
17.

Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysis.

Behrens G, Rijnders B, Nelson M, Orkin C, Cohen C, Mills A, Elion RA, Vanveggel S, Stevens M, Rimsky L, Thorpe D, Bosse M, White K, Zhong L, DeMorin J, Chuck SK.

AIDS Patient Care STDS. 2014 Apr;28(4):168-75. doi: 10.1089/apc.2013.0310. Epub 2014 Mar 24.

PMID:
24660840
[PubMed - indexed for MEDLINE]
18.

Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE).

Shaffer D, Hughes MD, Sawe F, Bao Y, Moses A, Hogg E, Lockman S, Currier J.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):155-63. doi: 10.1097/QAI.0000000000000131.

PMID:
24562349
[PubMed - indexed for MEDLINE]
19.

Characterization of HIV-1 drug resistance development through week 48 in antiretroviral naive subjects on rilpivirine/emtricitabine/tenofovir DF or efavirenz/emtricitabine/tenofovir DF in the STaR study (GS-US-264-0110).

Porter DP, Kulkarni R, Fralich T, Miller MD, White KL.

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):318-26. doi: 10.1097/QAI.0000000000000017.

PMID:
24525469
[PubMed - indexed for MEDLINE]
20.

Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial.

ENCORE1 Study Group, Puls R, Amin J, Losso M, Phanuphak P, Nwizu C, Orrell C, Young B, Shahar E, Wolff M, Gazzard B, Read T, Hill A, Cooper DA, Emery S.

Lancet. 2014 Apr 26;383(9927):1474-82. doi: 10.1016/S0140-6736(13)62187-X. Epub 2014 Feb 10. Erratum in: Lancet. 2014 Apr 26;383(9927):1464.

PMID:
24522178
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk